Investing Ideas
/
Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

6 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
DESN Dottikon ES Holding	CHF 209.50	-7.1%	-2.1%	CHF 2.9b	CHF 350.00	PE38.3x	S16.4%	0%
COPN Cosmo Pharmaceuticals	CHF 63.20	-2.2%	6.2%	CHF 1.0b	CHF 98.37	PE15.5x	E21.5%	3.0%
BSLN Basilea Pharmaceutica	CHF 41.20	-2.9%	18.9%	CHF 499.4m	CHF 77.25	PS3.4x	E14.9%	0%
MOLN Molecular Partners	CHF 4.85	5.4%	17.1%	CHF 178.8m	CHF 9.75	PS29.8x	E10.2%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 12.32	-15.4%	22.2%	CHF 154.2m	CHF 32.00	PE2.5x	E30.3%	n/a
ADXN Addex Therapeutics	CHF 0.061	-5.6%	10.5%	CHF 6.0m	CHF 0.16	PS10.2x	E0.6%	n/a

Page 1 of 1